Long-term Survival in Hilar Cholangiocarcinoma also Possible in Unresectable Patients
Radical resection remains the only curative treatment for hilar cholangiocarcinoma (HCCA). Only a limited proportion of patients, however, are eligible for resection. The survival and prognostic factors of these patients are largely unknown. The aim of this study was to evaluate survival and prognostic factors in unresectable patients presenting with HCCA.
We performed a cohort study of the denominator of HCCA patients seen in a tertiary referral center between March 2003 and March 2009. Demographics, treatment, pathology results, and survival were analyzed.
A total of 217 patients with suspected HCCA were identified. Ninety-five patients (40 %) underwent laparotomy, and in 57 (63 %) of these patients resection was performed. Overall median and 5-year survival of resected patients were 37 months and 43 %, respectively, as compared to 13 months and 7 % in unresectable patients. In unresectable patients, median survival was better in patients with locally advanced disease (16 months) as compared to patients with hepatic and extrahepatic metastases (5 and 3 months, p < 0.001). Of the 160 unresectable patients, 17 (10 %) survived longer than 3 years.
Of the patients presenting with HCCA in our center, 26 % proved resectable. The 7 % long-term survival rate of unresectable patients is remarkable and emphasizes the indolent growth of some of these tumors. Patients with metastases had a much worse prognosis with a median of 4 months.
- Dinant S, Gerhards MF, Rauws EA et al (2006) Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor). Ann Surg Oncol 13(6):872–880 CrossRef
- Ito F, Cho CS, Rikkers LF et al (2009) Hilar cholangiocarcinoma: current management. Ann Surg 250(2):210–218 CrossRef
- Kloek JJ, Ten Kate FJ, Busch OR et al (2008) Surgery for extrahepatic cholangiocarcinoma: predictors of survival. HPB (Oxford) 10(3):190–195 CrossRef
- Connor S, Barron E, Redhead DN et al (2007) Palliation for suspected unresectable hilar cholangiocarcinoma. Eur J Surg Oncol 33(3):341–345 CrossRef
- Ito F, Agni R, Rettammel RJ et al (2008) Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ann Surg 248(2):273–279 CrossRef
- Jarnagin WR, Bowne W, Klimstra DS et al (2005) Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg 241(5):703–712 CrossRef
- Kawasaki S, Imamura H, Kobayashi A et al (2003) Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg 238(1):84–92
- Witzigmann H, Berr F, Ringel U et al (2006) Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg 244(2):230–239 CrossRef
- Jarnagin WR, Fong Y, DeMatteo RP et al (2001) Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234(4):507–517 CrossRef
- Van Gulik TM, Kloek JJ, Ruys AT et al (2011) Multidisciplinary management of hilar cholangiocarcinoma (Klatskin tumor): extended resection is associated with improved survival. Eur J Surg Oncol 37(1):65–71 CrossRef
- Ruys AT, Bennink RJ, van Westreenen HL et al (2011) FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma. HPB (Oxford) 13(4):256–262 CrossRef
- Ruys AT, Busch OR, Gouma DJ et al (2011) Staging laparoscopy for hilar cholangiocarcinoma: is it still worthwhile? Ann Surg Oncol 18(9):2647–2653 CrossRef
- de Graaf W, van Lienden KP, Van Gulik TM et al (2010) (99 m)Tc-mebrofenin hepatobiliary scintigraphy with SPECT for the assessment of hepatic function and liver functional volume before partial hepatectomy. J Nucl Med 51(2):229–236 CrossRef
- de Graaf W, van Lienden KP, van den Esschert JW et al (2011) Increase in future remnant liver function after preoperative portal vein embolization. Br J Surg 98(6):825–834 CrossRef
- Kloek JJ, van der Gaag NA, Aziz Y et al (2010) Endoscopic and percutaneous preoperative biliary drainage in patients with suspected hilar cholangiocarcinoma. J Gastrointest Surg 14(1):119–125 CrossRef
- Igami T, Nishio H, Ebata T et al (2010) Surgical treatment of hilar cholangiocarcinoma in the “new era”: the Nagoya University experience. J Hepatobiliary Pancreat Sci 17(4):449–454 CrossRef
- Valle J, Wasan H, Palmer DH et al (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362(14):1273–1281 CrossRef
- Farrell RJ, Jain AK, Brandwein SL et al (2001) The combination of stricture dilation, endoscopic needle aspiration, and biliary brushings significantly improves diagnostic yield from malignant bile duct strictures. Gastrointest Endosc 54(5):587–594 CrossRef
- Kurzawinski TR, Deery A, Dooley JS et al (1993) A prospective study of biliary cytology in 100 patients with bile duct strictures. Hepatology 18(6):1399–1403 CrossRef
- Erdogan D, Kloek JJ, Ten Kate FJ et al (2008) Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures. Br J Surg 95(6):727–734 CrossRef
- Sugiyama M, Atomi Y, Wada N et al (1996) Endoscopic transpapillary bile duct biopsy without sphincterotomy for diagnosing biliary strictures: a prospective comparative study with bile and brush cytology. Am J Gastroenterol 91(3):465–467
- Nakeeb A, Tran KQ, Black MJ et al (2002) Improved survival in resected biliary malignancies. Surgery 132(4):555–563 CrossRef
- Long-term Survival in Hilar Cholangiocarcinoma also Possible in Unresectable Patients
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
World Journal of Surgery
Volume 36, Issue 9 , pp 2179-2186
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Surgery, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands
- 2. Department of Gastroenterology and Hepatology, Academic Medical Centre, Amsterdam, The Netherlands